Investing
US President Donald Trump’s first week in office brought a flurry of activity, with executive orders and tech developments signaling a shift toward the...
Hi, what are you looking for?
US President Donald Trump’s first week in office brought a flurry of activity, with executive orders and tech developments signaling a shift toward the...
US President Donald Trump’s first week in office brought a flurry of activity, with executive orders and tech developments signaling a shift toward the...
US President Donald Trump’s first week in office brought a flurry of activity, with executive orders and tech developments signaling a shift toward the...
SHANGHAI (Reuters) – China left its benchmark lending rates unchanged at the monthly fixing on Friday, matching market expectations, as falling yields, shrinking net...
Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on...
Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on...
By Jamie McGeever (Reuters) – A look at the day ahead in Asian markets. As the dust settles on a remarkable 24 hours of...
By David Lawder WASHINGTON (Reuters) – A group of 37 Democratic lawmakers on Thursday urged the U.S. Trade Representative’s office to press ahead with...
BRASILIA (Reuters) – Brazil’s lower house of Congress on Thursday gave its final approval to a watered-down proposal to cut public spending, part of...
By Lisa Baertlein and Abhinav Parmar (Reuters) -FedEx announced the much-anticipated spinoff of its freight trucking division on Thursday, as it restructures its operations...
QUITO (Reuters) – The IMF on Thursday said its executive board completed the first review of an extended fund facility for Ecuador, allowing for...
Cardiol Therapeutics President and CEO, David Elsley PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics President and CEO, David Elsley,...
Cardiol Therapeutics President and CEO, David Elsley PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics President and CEO, David Elsley,...
Capital Economics predicts strong headwinds to growth in 2025 for emerging markets, with expectations falling below the consensus. The firm anticipates that while the...
Czech Central Bank (CNB) maintained its policy rate at 4.00% on Thursday, pausing its recent sequence of rate cuts, which leads Capital Economics to...